室间隔缺损

Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol. 2008 Dec 2;52(23):e143-263.

• 全文
• 摘要

Sable C, Foster E, Uzark K, et al. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation. 2011;123:1454-1485.

• 全文
• 摘要

Beghetti M, Galiè N. Eisenmenger syndrome: a clinical perspective in a new therapeutic era of pulmonary hypertension. J Am Coll Cardiol. 2009;53:733-740.

• 摘要

Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation. 2012;125:324-334.

• 全文
• 摘要

1.  Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol. 2008 Dec 2;52(23):e143-263.

• 全文
• 摘要

2.  Brickner ME, Hillis DL, Lange RA. Congenital heart disease in adults: first of two parts. N Engl J Med. 2000;342:256-263.

• 摘要

3.  Perloff JK. Survival patterns without cardiac surgery or interventional catheterization: a narrowing base. In: Perloff JK, Childs JS, eds. Congenital heart disease in adults. 2nd ed. Philadelphia, PA: WB Saunders; 1998:15-53.

4.  Graham TP Jr, Gutgesell HP. Ventricular septal defects. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, eds. Moss and Adams heart disease in infants, children, and adolescents. Baltimore, MD: Williams & Wilkins, 1995:724-746.

5.  Craig B. Atrioventricular septal defect: from fetus to adult. heart. 2006;92:1879-1885.

• 摘要

6.  Tubman RJ, Shields MD, Craig BG, et al. Congenital heart disease in Down's syndrome: two year prospective early screening study. BMJ. 1991;302:1425-1427.

• 摘要

7.  Reller MD, Strickland MJ, Riehle-Colarusso, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Paediatr. 2008;153:807-813.

• 摘要

8.  Libby P, Bonow RO. Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. London, UK: WB Saunders; 2008.

9.  Birnbaum Y, Fishbein MC, Blanche C, et al. Ventricular septal defect after acute myocardial infarction. New Engl J Med. 2002;347:1426-1432.

• 摘要

10.  Burd L, Deal E, Rios R, et al. Congenital heart disease and fetal alcohol spectrum disorders. Congenit Heart Dis. 2007;2:250-255.

• 摘要

11.  Fuster V, Walsh RA, O'Rourke RA, et al. Hurst's the heart, 12th edition. New York, NY: McGraw-Hill; 2007.

12.  Magee AG, Boutin C, McCrindle BW, et al. Echocardiography and cardiac catheterization in the preoperative assessment of ventricular septal defect in infancy. Am Heart J. 1998;135:907-913.

• 摘要

13.  Sable C, Foster E, Uzark K, et al. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation. 2011;123:1454-1485.

• 全文
• 摘要

14.  Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014;63:1159-1168.

• 全文
• 摘要

15.  Szkutnik M, Qureshi SA, Kusa J, et al. Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart. 2007;93:355-358.

• 摘要

16.  Masura J, Gao W, Gavora P, et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study. Pediatr Cardiol. 2005;26:216-219.

• 摘要

17.  Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol. 2006;47:319-325.

• 摘要

18.  Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007;50:1189-1195.

• 摘要

19.  Beghetti M, Galiè N. Eisenmenger syndrome: a clinical perspective in a new therapeutic era of pulmonary hypertension. J Am Coll Cardiol. 2009;53:733-740.

• 摘要

20.  Galiè N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114:48-54.

• 摘要

21.  Chau EM, Fan KY, Chow WH. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. Int J Cardiol. 2007;120:301-305.

• 摘要

22.  Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003;91:362-365.

• 摘要

23.  Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation. 2012;125:324-334.

• 全文
• 摘要

24.  Waddell TK, Bennett L, Kennedy R, et al. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant. 2002;21:731-737.

• 摘要

25.  Stoica SC, McNeil KD, Perreas K, et al. Heart-lung transplantation for Eisenmenger syndrome: early and long-term results. Ann Thorac Surg. 2001;72:1887-1891.

• 摘要

26.  Perrotta S, Lentini S. In patients undergoing surgical repair of post-infarction ventricular septal defect, does concomitant revascularization improve prognosis? Interact Cardiovasc Thorac Surg. 2009;9:879-887.

• 全文
• 摘要

27.  Landzberg MJ, Lock JE. Transcatheter management of ventricular septal rupture after myocardial infarction. Semin Thorac Cardiovasc Surg. 1998;10:128-132.

• 摘要

28.  Pesonen E, Thilen U, Sandstrom S, et al. Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device. Scand Cardiovasc J. 2000;34:446-448.

• 摘要

29.  Gabriel HM, Heger M, Innerhofer P, et al. Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol. 2002;39:1066-1071.

• 摘要

30.  Gatzoulis MA, Beghetti M, Galiè N, et al. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol. 2008;127:27-32.

• 摘要

31.  Galiè N, Torbicki A, Barst R, et al; European Society of Cardiology. ESC guidelines on diagnosis and treatment of pulmonary arterial hypertension. Eur Heart J. 2004;25:2243-2278.

• 全文
• 摘要

32.  Pienvichit P, Piemonte TC. Percutaneous closure of postmyocardial infarction ventricular septal defect with the CardioSEAL septal occluder implant. Catheter Cardiovasc Interv. 2001;54:490-494.

• 摘要

33.  Ogino H, Miki S, Ueda Y, et al. Surgical management of aortic regurgitation associated with ventricular septal defect. J Heart Valve Dis. 1997;6:174-178.

• 摘要

34.  Predescu D, Chaturvedi RR, Friedberg MK, et al. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008;136:1223-1228.

• 摘要

35.  Mylonakis E, Calderwood SB. Medical progress: infective endocarditis in adults. N Engl J Med. 2001;345:1318-1330.

• 摘要